ProPharma Group (Linden Capital Portfolio) Acquires Southwood Research

March 11, 2019

ProPharma Group, a portfolio company of Linden Capital Partners, has acquired Southwood Research, a Buckinghamshire-based provider of pre-approval regulatory science services to the pharmaceutical and biotech industries. The add-on expands ProPharma's regulatory affairs capabilities across the EU and strengthens its end-to-end regulatory service offering.

Buyers
ProPharma Group, Linden Capital Partners
Targets
Southwood Research
Platforms
ProPharma Group
Location
Buckinghamshire, United Kingdom
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.